FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease

FDA today approved Infilbray (venglustat) tablets, the first treatment for the neurological symptoms of Type 3 Gaucher disease (GD3) in adults and pediatric patients weighing at least 15 kg (approximately 33 pounds).
Kaynak: FDA Press Releases


